KSB Chief Managing Director Projects 10-15% Volume Growth

Market snapshot: KSB Limited's Chief Managing Director, Rajiv Jain, has projected a volume growth of 10-15% for the company, while aiming for a 15-17% increase in value (as stated in the source alert; not independently verified). This projection comes amid solid top-line performance, with Q2 CY26 consolidated revenue increasing by 4.5% YoY to ₹691 cr, supported by a healthy total order book of ₹2,744.5 cr. However, near-term profitability remains under pressure due to margin compression and high employee costs, resulting in an 18.8% YoY decline in Q2 CY26 net profit to ₹57.2 cr.

Data Snapshot

• KSB Limited consolidated revenue from operations for Q2 CY26 rose 4.5% YoY to ₹691 cr from ₹661 cr.
• Consolidated net profit (PAT) fell 18.8% YoY to ₹57.2 cr in Q2 CY26 from ₹70.4 cr in Q2 CY25.
• The company's outstanding order book stood at ₹2,744.5 cr as of June 30, 2026, providing robust mid-term revenue visibility.

What's Changed

• Revenue growth: Q2 CY26 consolidated revenue rose 4.5% YoY to ₹691 cr, showing modest top-line momentum.
• Profit contraction: Consolidated PAT fell 18.8% YoY to ₹57.2 cr, down from ₹70.4 cr in Q2 CY25.
• EBITDA margin pressure: EBITDA margins contracted by 310 bps to 13.2% from 16.3% YoY, driven by higher employee costs and valves segment weakness.

Key Takeaways

• Volume and Value Targets: The CMD projected a 10-15% growth in volume, alongside an unverified 15-17% targeted increase in value.
• Robust Order Pipeline: Order book stands strong at ₹2,744.5 cr as of June 2026, offering multi-year revenue visibility.
• Capacity Ramping: A 20% capacity expansion at the Shirwal plant (targeting ~1,450 pumps annually) and a new storage shed will cater to growing domestic nuclear opportunities.
• Segment Performance Divergence: In Q2 CY26, the Pumps division grew by 5.4%, while the Valves segment declined by 4.8% and its segment profit plummeted by 74.7%.

SAHI Perspective

KSB's medium-term outlook is backed by strong sector tailwinds in nuclear energy, water infrastructure, and data centres, supported by a healthy ₹2,744.5 cr order book. However, the current divergence in segment performance is a concern, with the valves segment severely dragging down profitability. Investors must monitor if the 20% Shirwal capacity expansion and SAP S/4HANA implementation can successfully drive operational efficiencies and reverse the margin contraction.

Market Implications

The projected volume growth of 10-15% is positive for the capital goods and industrial pumps ecosystem, signaling healthy underlying demand in infrastructure and energy sectors. However, the operational headwinds and margin squeeze observed in Q2 CY26 may limit immediate stock outperformance, keeping valuations under check until EBITDA margins recover back to the targeted 13-14% range.

Trading Signals

Market Bias: Neutral

Strong revenue visibility with a robust order book of ₹2,744.5 cr as of June 30, 2026, and management's volume growth target of 10-15% are counterbalanced by immediate margin contraction, with Q2 CY26 EBITDA margins declining to 13.2% from 16.3 in Q2 CY25 due to a drag in the valves segment.

Overweight: Pumps, Nuclear Power Gear, Water Infrastructure

Underweight: Valves Segment

Trigger Factors:

• Ramp-up in nuclear project deliveries (Kudankulam & Kaiga)
• EBITDA margin recovery in the valves segment
• Commodity price stabilization (steel, copper)

Time Horizon: Medium-term (3-12 months)

Industry Context

India's nuclear gear manufacturing sector is witnessing massive capacity expansions, driven by legislative developments like the SHANTI Act. Key players like KSB, Tema India, and Walchandnagar Industries are scaling operations to capture this multi-billion dollar opportunity. KSB's strong positioning is reflected in its ₹1,235 cr nuclear order book, which forms nearly 45% of its total order book of ₹2,744.5 cr.

Key Risks to Watch

• Margin volatility: Persistent pressure from rising employee costs and commodity prices (such as steel and copper).
• Valves segment underperformance: Continued profitability drag in the valves division which fell 74.7% in Q2 CY26.
• Execution delays: Long order-to-delivery cycles of 24-36 months in the nuclear segment could delay revenue recognition.

Recent Developments

On August 6, 2026, KSB announced capacity expansion plans via SEBI/LODR filing for the construction of an additional shed at its Shirwal plant. Earlier, on May 5, 2026, KSB announced significant order wins from NTPC power plants (Nabinagar and Gadarwara) and Kazakhstan exports.

Closing Insight

While KSB faces immediate margin compression, its robust backlog and volume expansion goals demonstrate strong structural growth. Stabilizing segment performance will be the key catalyst for valuation rerating.

High Performance Trading with SAHI.